Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

HRT: FDA recommends short-term, low-dose use

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    HRT: FDA recommends short-term, low-dose use. React. Wkly. 943, 3 (2003). https://doi.org/10.2165/00128415-200309430-00005

    Download citation

    Keywords

    • Public Health
    • Breast Cancer
    • Cardiovascular Event
    • Hormone Therapy
    • Class Labelling